Jianbin Bi

机构：Guangxi Medical University, Tumor Hospital of Guangxi Medical University · ORCID：0000-0002-7703-4765

发表论文 96 篇 · 总被引 1591 次 · h-index 26

代表论文

• Bioinformatics analysis and experimental validation of cuproptosis-related lncRNA LINC02154 in clear cell renal cell carcinoma (2023 · BMC Cancer · 被引 36)
• CACA guidelines for holistic integrative management of prostate cancer (2024 · Holistic Integrative Oncology · 被引 22)
• A novel focal adhesion-related risk model predicts prognosis of bladder cancer —— a bioinformatic study based on TCGA and GEO database (2022 · BMC Cancer · 被引 16)
• In vitro and in vivo assessment of a bilayered degradable rapamycin-eluting stent for ureteral stricture caused by holmium: YAG laser lithotripsy (2023 · Acta Biomaterialia · 被引 15)
• In silico development and experimental validation of a novel 7-gene signature based on PI3K pathway-related genes in bladder cancer (2022 · Functional & Integrative Genomics · 被引 15)
• Identification of fatty acid metabolism-based molecular subtypes and prognostic signature to predict immune landscape and guide clinical drug treatment in renal clear cell carcinoma (2023 · International Immunopharmacology · 被引 11)